Elevance Health, Inc. ELV

396.09 (2.16) (0.54%) as of 25 Sep
Market cap
$86.4B
P/E
17.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

12.58% 13.25% 12.10% 11.17%
ROA
4.62% 4.75% 4.27% 4.00%
ROIC
13.32% 12.74% 12.52% 11.83%
Return on Tangible Assets
20.08% 21.25% 19.87% 18.00%
Average Days of Receivables
41.87 39.49 41.51 42.45
Free Cash Flow per Share
16.87 14.17 29.34 28.98
Free Cash Flow
3,767.00 3,174.00 6,450.00 6,289.00
Capital Expenditures
(1,145.00) (1,116.00) (1,155.00) (1,175.00)
Piotroski F-Score
4.00 5.00 6.00 5.00
Other line items
Cash ROIC
4.38% 3.83% 6.78% 6.57%
Accounts Receivable Turnover
9.56 9.81 8.91 8.65
Accounts Payable Turnover
7.38 7.20 7.01 6.89
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
51.29 52.59 52.83 53.66
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.22) (0.16) (0.16) (0.16)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Share Based Compensation of Revenue
0.11% 0.14% 0.12% 0.12%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.89 0.76 1.45 1.50
Depreciation/Fixed assets
0.33 0.33 0.33 0.33
Capex/Depreciation
(0.74) (0.72) (0.76) (0.78)
Revenue per Share
872.46 888.95 911.81 926.79
Operating CF per Share
22.00 19.15 34.60 34.40
Capex per Share
(5.13) (4.98) (5.25) (5.41)
Capex to Sales
0.01 0.01 0.01 0.01
Net Profit Margin
2.84% 2.84% 2.62% 2.47%

Fold the line items

Columns are period end dates